Search clinical trials for: depot naltrexone

Total 1003 results

NYU Langone Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Extended-release Naltrexone and Care Management for Alcohol Dependent Frequent Emergency Department Users

Alcohol Dependence | Alcohol Use Disorder

United States
University of Pennsylvania
National Institute on Drug Abuse (NIDA); Alkermes, Inc.

Completed

VIVITROL as a Treatment for Cocaine and Alcohol Dependence

Alcohol Dependence | Cocaine Dependence

United States
Women and Infants Hospital of Rhode Island

Unknown

The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

Grade 1 Endometrial Endometrioid Adenocarcinoma | Grade 2 Endometrial Endometrioid Adenocarcinoma | Complex Atypical Endometrial Hyperplasia

United States
Thunder Bay Regional Research Institute

Withdrawn

Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound

Uterine Leiomyoma

Canada
Allodynic Therapeutics, Inc

Not yet recruiting

Multi-Center Study of Naltrexone-Acetaminophen in Acute Migraine, With an Exploratory Analysis of Co-occurring Anxiety

Migraine
Mundipharma (China) Pharmaceutical Co. Ltd

Unknown

Buprenorphine Transdermal Patches Pharmacokinetic Study

Chronic Pain

China
Pfizer

Terminated

Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain

Moderate-severe Pain

United States
Pfizer

Terminated

Conversion to Embeda With Rescue Trial (ConvERT)

Pain | Chronic Disease

United States
NYU Langone Health
National Institute on Drug Abuse (NIDA); University of California, Los Angeles and other collaborators

Completed

Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry (XOR)

Opioid-Related Disorders | Heroin Dependence

United States
Glenn-Milo Santos
National Institute on Drug Abuse (NIDA)

Active, not recruiting

Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM

Methamphetamine Use Disorder

United States
GlaxoSmithKline

Completed

[11C]Carfentanil PET Study of GSK1521498

Obesity

United Kingdom
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Dronabinol Naltrexone Treatment for Opioid Dependence (Domino)

Opioid Dependence

United States
Copenhagen University Hospital at Herlev

Withdrawn

Palliative Treatment of Ulcerated Cutaneous Metastases: Trial Between Electrochemotherapy and Radiotherapy

Ulcerated Cutaneous Metastases

Denmark
Universidad Francisco de Vitoria
University of Seville; University of Greenwich

Completed

Ingestion of Beta-alanine Effects in Well-trained Tennis Players (BETA_TENNIS)

Beta-alanine | Placebo

Spain
Nationwide Children's Hospital
Society of Family Planning

Completed

Drug Exposure and Depot Medroxyprogesterone Acetate (DMPA) in Adolescent Subjects

Disorder of Bone Density and Structure, Unspecified | Weight Gain | Uterine Bleeding

United States
University of Pennsylvania

Not yet recruiting

Brain Mechanisms of Pharmacotherapy in Opioid Use Disorder

Opioid Dependence
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Recruiting

Long-acting Naltrexone for Pre-release Prisoners

Opiate Addiction

United States
Alza Corporation, DE, USA

Completed

A Study to Evaluate the Safety of D-TRANS Fentanyl With Naltrexone in Adult Patients With Chronic Pain and Who Are Opioid Tolerant

Chronic Pain
Federal University of São Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo; Associacao Fundo de Incentivo...

Completed

Effects of Omegas 3 and 6 on Alcohol Dependence

Alcohol Dependence

Brazil
National Development and Research Institutes, Inc.
St. Luke's-Roosevelt Hospital Center

Unknown

Science-Based Treatment for Opioid-Dependent Adolescents

Opioid-Dependence Among Adolescents

United States
Central Institute of Mental Health, Mannheim
German Federal Ministry of Education and Research; Heidelberg University -... and other collaborators

Completed

Oxytocin and Naltrexone: Investigation of Combined Effects on Stress- and Alcohol Cue-induced Craving in Alcohol Use Disorder (ON-ICE)

Alcoholism | Alcohol Use Disorder | Alcohol Addiction

Germany
Allodynic Therapeutics, LLC

Completed

Low-Dose Naltrexone and Acetaminophen Combination in the Treatment of Chronic Low Back Pain (ANODYNE-4)

Chronic Low Back Pain | Lumbar Radiculopathy

United States
Ensysce Biosciences
PRA Health Sciences

Completed

Study of PF614 Compared to OxyContin® in Healthy Volunteers (SAD)

Healthy

United States
Pfizer

Completed

A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain

Low Back Pain | Chronic Pain | Analgesia

United States
University of Vermont Medical Center
National Institute on Drug Abuse (NIDA)

Completed

Effective Treatment for Prescription Opioid Abuse

Prescription Opioid Dependence

United States
Allodynic Therapeutics, Inc

Completed

The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination

Migraine With or Without Aura

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Extended Release Naltrexone for Opioid-Dependent Youth

Drug Dependence

United States
Elite Laboratories, Inc

Completed

A Study to Evaluate Withdrawal Effects Following Dosing of Oxycodone/Naltrexone in Methadone-Maintained Subjects

Withdrawal Symptoms

United States
Camurus AB

Active, not recruiting

A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly

Acromegaly

United States, Spain, United Kingdom, Germany, Russian Federation, Greece, Hungary, Italy, Poland, Turkey, Serbia
SCRI Development Innovations, LLC
Ipsen

Terminated

Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres

Gastrointestinal Neoplasms | Neuroendocrine Tumors | Carcinoid Tumors

United States
AstraZeneca

Withdrawn

Protection of Ovarian Function With Goserelin Acetate in Premenopausal Early Breast Cancer Patients With Chemotherapy (PROOF)

Breast Cancer | Ovarian Function

Turkey
Novartis

Completed

Sandostatin LAR® Depot in Patients With Primary Insulin Hypersecretion (PIH) and at Least Moderate Obesity

Obesity | Primary Insulin Hypersecretion

United States
Friends Research Institute, Inc.

Recruiting

Extended Release Naltrexone Versus Extended Release Buprenorphine With Individuals Leaving Jail

Opioid-use Disorder

United States
Pfizer

Completed

Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo

Chronic Pain | Analgesia | Opioid-related Disorders | Narcotic Abuse
Minia University

Completed

The Use of Naltrexone Hydrochloride to Promote Healing in Patients With Resistant Non-infectious Corneal Ulcer

Cornea Ulcer

Egypt
Pfizer

Completed

Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain

Chronic Noncancer Pain

United States
Pfizer

Completed

Study of Embeda (Kadian NT, ALO-01) in Subjects With Chronic Moderate to Severe Nonmalignant Pain

Pain

United States
Camurus AB
Novartis

Completed

Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs)

Neuroendocrine Tumors | Acromegaly

Germany, Sweden, France, Italy
MedImmune LLC

Completed

An Epidemiological Study to Evaluate the RSV-Associated Lower Respiratory Track in Infections in Infants

Apnea | Pneumonia | Bronchiolitis | Respiratory Infections

United States
Newcastle University

Completed

Revival of Stem Cells in Addison's Study (RoSA)

Adrenal Failure

United Kingdom
Aswan University Hospital

Unknown

17-Alpha-Hydroxyprogesterone Caproate in Pregnant Women With Placenta Previa

Placenta Previa

Egypt
University of Chicago

Completed

N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence

Methamphetamine Dependence

United States
Centro Universitario La Salle
Hospital de Clinicas de Porto Alegre

Completed

LDN and tDCS in Fibromyalgia

Fibromyalgia

Brazil
University of California, Los Angeles
Alkermes, Inc.

Completed

Injectable Pharmacotherapy for Opioid Use Disorders (IPOD) (IPOD)

Opioid Use Disorders

United States
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA); Research Foundation for Mental Hygiene...

Completed

Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana

Marijuana Smoking

United States
Bankole Johnson

Completed

Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study

Alcoholism

United States
Alza Corporation, DE, USA

Completed

An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg

Analgesia
Planned Parenthood Federation of America
Pfizer; Tara Health Foundation

Completed

Depo Provera Self-Administration Study: Putting a Patient-Centered Practice to the Test at Planned Parenthood (DSAS)

Contraception

United States
Pfizer

Completed

A Study of Embeda (Kadian NT, ALO-01) in Subjects With Pain Due to Osteoarthritis of the Hip or Knee

Osteoarthritis | Chronic Pain

United States
Dana-Farber Cancer Institute
Medivation, Inc.

Completed

Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

Prostate Cancer | Prostate Adenocarcinoma | High Risk Prostate Cancer

United States

Search clinical trials for: depot naltrexone

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uruguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations